Beth A. Drolet, MD 

Dermatology

Title(s): Professor, Dermatology and Pediatrics, chief, Division of Pediatric Dermatology, Medical College of Wisconsin; medical director, Dermatology, Birthmarks and Vascular Anomalies Center, Children's Hospital of Wisconsin.

Education: Medical degree, Loyola University, Chicago, 1991; internship, Medicine, University of Colorado, 1992; residency, Dermatology, Medical College of Wisconsin, 1995; fellowship, Clinical Research and Pediatric Dermatology, Medical College of Wisconsin, 1996.

Certifications: American Board of Dermatology, American Board of Dermatology, Pediatric Dermatology, licensure, Wis.

Honors: Loyola University Student Research Fellowship; Alpha Omega Alpha; Best Doctors in Milwaukee (Milwaukee Magazine) 2004, 2006 and 2007; American Skin Association Research Award, 2004; Patient Directed Investigation Award, Dermatology Foundation, 2004; Society for Pediatric Dermatology Research Award, 2006; Small Business Times Health Care Hero Award, 2006.

Research interests: Hemangiomas of infancy, large facial hemangiomas and associated vascular anomalies.

Representative publications:

• Haggstrom AN, Drolet BA, Baselga E, Chamlin S, Esterly NB, Garzon J, Horii K, Lucky A, Metry DW, Mancini AJ, Nopper A, Frieden IJ. Prospective Study of Infantile Hemangiomas, Part 1: Demographic, Prenatal and Perinatal Characteristics. Journal of Pediatrics. 150: 291-294, 2007.
• Maronn M, Corden T, Drolet BA. Pnuemocytosis Carinii Pneumonia in Infant Treated with Oral Steroids for Hemangioma. Archives of Dermatology. 143:1224-1225, 2007.
• Chamlin SL, Haggstrom AN, Drolet BA, Baselga E, Frieden IJ, Garzon MC, Horii KA, Lucky AW, Metry DW, Newell B, Mancini AJ. Ulcerated Hemangiomas of Infancy: Who, What, Where and When? Journal of Pediatrics. 151:684-689, 2007.
• Metry DW, Siegel D, Cordisco MR, Pope E, Prendiville J, Drolet BA, Horii K, Liang M, Stein S, Frieden IJ. A Comparison of Disease Severity Among Affected Mles. Archives of Dermatology. Epub ahead of print 2007.
• Drolet BA, Frieden IJ. Infantile Hemangiomas: An Emerging Health Issue Linked to an Increasing Rate of Low Birth Weight Infants in the United States. Journal of Pediatrics (submitted).

Current grants:

• Phase II Clinical Trial Assessing Efficacy and Safety of Oral Prednisolone vs. Vincristine in the Treatment of Infantile Hemangiomas, Food and Drug Administration OPD Grant Program, 1/08-1/11. Co-principal investigator.
• Immune Suppression of Infants Treated with Oral Corticosteroids for Infantile Hemangiomas, Society for Pediatric Dermatology, 11/15/06-11/14/08. Principal investigator.
• Immune Suppression of Infants Treated with Oral Corticosteroids for Infantile Hemangiomas, Research Affairs Committee, Medical College of Wisconsin, 11/1/07-6/30/08. Principal investigator.
• Large Facial Hemangiomas and Associated Vascular Anomalies, Children's Research Institute, 2/15/05-13/31/07. Principal investigator.
• Multifocal Lymphangioendotheliomatosis with Thrombocytopenia, Children's Research Institute. Principal investigator.
• Prospective Cohort Study of Hemangiomas of Infancy, Spirit Foundation 10/03-12/08. Principal investigator.
• Phase II Clinical Trial Assessing Efficacy and Safety of Oral Prednisolone vs. Vincristine in the Treatment of Infantile Hemangiomas, Greater Milwaukee Foundation, 6/07-6/10. Co-principal investigator.
• Genomewide Association Study on Infantile Hemangiomas, Bleser Family Foundation (through Children's Hospital of Wisconsin Foundation), 12/06-12/09. Principal investigator.
• Phase II Clinical Trial Assessing Efficacy and Safety of Oral Prednisolone vs. Vincristine in the Treatment of Infantile Hemangiomas, Bleser Family Foundation (through Children's Hospital of Wisconsin Foundation), 12/07-12/10. Co-principal investigator.

Contact information: 8701 Watertown Plank Road, Milwaukee, WI 53226. Phone: (414) 266-1569. Fax: (414) 266-4778. E-mail: drolet@mcw.edu.